Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.

MLA

Llosa, Nicolas J., et al. “Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 23, no. 12, Dec. 2017, pp. 2127–36. EBSCOhost, https://doi.org/10.1016/j.bbmt.2017.08.012.

APA

Llosa, N. J., Cooke, K. R., Chen, A. R., Gamper, C. J., Klein, O. R., Zambidis, E. T., Luber, B., Rosner, G., Siegel, N., Holuba, M. J., Robey, N., Hayashi, M., Jones, R. J., Fuchs, E., Holdhoff, M., Loeb, D. M., & Symons, H. J. (2017). Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 23(12), 2127–2136. https://doi.org/10.1016/j.bbmt.2017.08.012

Chicago

Llosa, Nicolas J, Kenneth R Cooke, Allen R Chen, Christopher J Gamper, Orly R Klein, Elias T Zambidis, Brandon Luber, et al. 2017. “Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23 (12): 2127–36. doi:10.1016/j.bbmt.2017.08.012.